Adaptive Biotechnologies (ADPT) Director Owen Katey Einterz Gifts 12,539 Shares

What Happened

• Owen Katey Einterz, a director of Adaptive Biotechnologies (ADPT), reported a disposition by gift of 12,539 shares on August 31, 2026. The filing lists no price because this was a bona fide gift (footnote F1).

Key Details

• Transaction date: 2026-08-31
• Transaction type/code: Gift (G)
• Shares disposed: 12,539
• Price: N/A (footnote F1 — price not applicable for bona fide gifts)
• Filing date / accession: Report filed 2026-09-02 (Accession 0001852578-26-000007) — appears to be filed within the normal Form 4 reporting window
• Shares owned after transaction: Not specified in the provided Form 4 excerpt
• Footnote: F1 indicates price is not applicable to dispositions resulting from bona fide gifts

Context

• Gifts are dispositions, not open-market sales, and typically reflect personal, tax, or estate-planning decisions rather than an immediate market view. They do not generate cash proceeds for the insider and should not be interpreted directly as a bullish or bearish signal.